10.05.2021 Views

The Operating Theatre journal April 2021

The Operating Theatre journal April 2021

The Operating Theatre journal April 2021

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Sheffield researchers to lead major study

seeking to understand what matters most

to patients with colitis and Crohn’s disease

Long days, late nights, on calls, working every weekend?

Long days, late nights, on calls, working every weekend?

…. …. you you won’t see this at at CHEC. CHEC.

We are We hiring are hiring Scrub Practitioners Nationwide

Community Health and Eyecare (CHEC) are the largest provider of community ophthalmology

Community Health and Eyecare (CHEC) are the largest provider of community ophthalmology

services in the UK, delivering over 200,000 outpatient appointments per year. Established in

services 2012 in the as a UK, provider delivering of NHS eyecare over 200,000 outside outpatient the hospital setting, appointments we continue per to year. grow Established rapidly. in

2012 as a provider of NHS eyecare outside the hospital setting, we continue to grow rapidly.

We are committed to high standards of patient care with 99% of patients recommending our

We are services committed to family to high and friends. standards of patient care with 99% of patients recommending our

services to family and friends.

Now is the time to join us as new state of the art hospitals are opening in the South East,

Midlands and North West regions.

Now is the time to join us as new state of the art hospitals are opening in the South East,

Midlands and • Our North competitive West regions. salaries range from £33k up to £38k dependent on experience.

• Personal bonus and company bonus schemes to reward your performance.

• Our • competitive No night shifts salaries or on calls range and from only occasional £33k up weekends. to £38k dependent on experience.

• Personal • 25 days bonus holiday. and company bonus schemes to reward your performance.

• Bespoke training and development plan.

• No night shifts or on calls and only occasional weekends.

• Employee Assistance Programme to support your wellbeing.

• 25

days

Better

holiday.

work life balance

• Bespoke training and development plan.

• Employee Assistance Programme to support your wellbeing.

If you like what you’ve read so far, we look forward to receiving your interest via email to

• Better work life balance

recruitment@chec.uk

If you like If you what would you’ve prefer read a conversation so far, we about look your forward career to feel receiving free to call your Daniel interest on 01772 via 286 email 168 to

CHEC out our website recruitment@chec.uk

for the latest career opportunities

https://www.communityeyecare.uk/careers/

If you would prefer a conversation about your career feel free to call Daniel on 01772 286 168

CHEC out our website for the latest career opportunities

https://www.communityeyecare.uk/careers/

The Infection Prevention Society is pleased to have collaborated with

NHS England and NHS Improvement in developing this educational video

on managing the risk of COVID-19 in healthcare settings.

Hierarchy of Controls: how to keep yourself and others safe from

COVID-19 - to access the video see: http://bit.ly/managingcovidriskPR

The aim of the video is to translate national infection prevention

and control guidance into readily accessible information, enabling

healthcare staff to understand and put into action the right measures

to prevent transmission of COVID-19. The video is focused on the

Hierarchy of Controls, including engineering, administrative and PPE

controls, and how these need to be applied in healthcare settings to

protect both staff and patients from COVID-19. It uses animation to

convey the key principles underpinning the IPC guidance in a simple

but informative way.

Prof Jennie Wilson, IPS President said ‘Adhering infection prevention

and control guidance for COVID-19 is critical to assuring the safety of

both patients and staff but healthcare staff often have little time to

read long complex documents. This video is an ideal way for staff to

find out about the key principles in a quick and accessible way’

Book Now

http://bit.ly/OTJRCoA2021

Patient Safety in Perioperative Practice

Tuesday 20 April 2021

Professor Alan Lobo (centre) and Professor Danny Hind (far right) outside the

Royal Hallamshire Hospital with nurses and practitioners from Sheffield’s

specialist inflammatory bowel centre

Sheffield Teaching Hospitals to lead £450,000 grant award that aims to

change the way healthcare services respond to the needs of those living

with inflammatory bowel disease

Researchers from Sheffield Teaching Hospitals NHS Foundation Trust are

to play a leading role in a major new study that aims to change the

way healthcare services respond to the needs of people living with

inflammatory bowel disease by putting the patient’s voice at the centre

of care.

The £450,000 grant award, which is being funded by the Health

Foundation’s Common Ambition programme, seeks to create

partnerships, led by people living with inflammatory bowel disease, to

co-design future services and improve care.

It is one of four national projects selected from over 350 national

applicants.

The research will be led by Professor Alan Lobo, Consultant

Gastroenterologist at Sheffield Teaching Hospitals in partnership with

the University of Sheffield and Crohn’s and Colitis UK.

It will build on previous research awards given to Professor Lobo and his

team at Sheffield’s inflammatory bowel disease centre that put patients

at the heart of decision-making.

The study evaluation will be led by Professor Dan Hind of the University

of Sheffield’s School of Health and Related Research, who are recognised

for their world leading health services research.

Advances in treatments of inflammatory bowel disease have been

rapid in the past few years, with more and more new drugs and

affordable therapies becoming available. This includes powerful drugs

that target the immune response and biosimilar drugs, newer versions

of original licensed biological drugs, that can be given to patients in

hospital through a drip or at home by injection pen. However, there

remain limitations in patients’ opportunities to express to healthcare

professionals what is important to them and to develop personalised

care.

During the three-year study, the team will actively engage with

lesser heard voices in the community, helped by independent charity

Voiceability, including those from ethnic minority backgrounds,

disadvantaged groups and women’s groups, to understand what matters

to them.

All 4,000 patients attending Sheffield’s specialist inflammatory bowel

centre will be invited to participate in a way that is accessible to them.

There will also be an app to deliver real time information from people

with inflammatory bowel disease to clinicians.

Professor Alan Lobo, Consultant Gastroenterologist at Sheffield Teaching

Hospitals NHS Foundation Trust and chief investigator of the study, said:

“This is a really exciting project which could represent a radical shift

in the way groups of healthcare services engage with patients. As one

of the largest inflammatory bowel disease centres in the country, this

is also excellent news #PSPP21 for Sheffield as we can recruit large numbers of

patients and engage with a huge and diverse population. We will be

communicating with all our patients about the study in due course, and

reaching out to lesser 5 CPD heard credits voices to further understand what matters

to them.”

Inflammatory bowel disease affects 300,000 people in the UK (or

roughly 1 in every 210 people). Crohn’s and colitis disease are the two

main forms of inflammatory bowel disease.

When responding to articles please quote ‘OTJ’

10 THE OPERATING THEATRE JOURNAL www.otjonline.com

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!